Divergent clonal evolution of castration resistant neuroendocrine prostate cancer

An increasingly recognized resistance mechanism to androgen receptor (AR)-directed therapy in prostate cancer involves epithelial plasticity, wherein tumor cells demonstrate low to absent AR expression and often neuroendocrine features. The etiology and molecular basis for these “alternative” treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Beltran, Himisha, Prandi, Davide, Mosquera, Juan Miguel, Benelli, Matteo, Puca, Loredana, Cyrta, Joanna, Marotz, Clarisse, Giannopoulou, Eugenia, Chakravarthi, Balabhadrapatruni V.S.K., Varambally, Sooryanarayana, Tomlins, Scott A., Nanus, David M., Tagawa, Scott T., Van Allen, Eliezer M., Elemento, Olivier, Sboner, Andrea, Garraway, Levi A., Rubin, Mark A., Demichelis, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777652/
https://www.ncbi.nlm.nih.gov/pubmed/26855148
http://dx.doi.org/10.1038/nm.4045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777652/
https://www.ncbi.nlm.nih.gov/pubmed/26855148
http://dx.doi.org/10.1038/nm.4045

Ejemplares similares